[
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock rises Monday, still underperforms market",
    "summary": "Boston Scientific Corp. stock rises Monday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=8082512e84c5ea2a2128fab3bc77688f0d81f73f434b5babb851cc2d2b7c45cf",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754325360,
      "headline": "Boston Scientific Corp. stock rises Monday, still underperforms market",
      "id": 136210406,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock rises Monday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=8082512e84c5ea2a2128fab3bc77688f0d81f73f434b5babb851cc2d2b7c45cf"
    }
  },
  {
    "ts": null,
    "headline": "AVTR Stock Declines as Q2 Earnings Miss Estimates, Revenues Down Y/Y",
    "summary": "Avantor stock dips more than 15% as Q2 EPS missed estimates, revenue declines year over year and lowers full-year guidance.",
    "url": "https://finnhub.io/api/news?id=82caca3ac5ad48d9f372abf1451b1472f9145e5d146a85a69ef6ec557accb14b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754323560,
      "headline": "AVTR Stock Declines as Q2 Earnings Miss Estimates, Revenues Down Y/Y",
      "id": 136200386,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Avantor stock dips more than 15% as Q2 EPS missed estimates, revenue declines year over year and lowers full-year guidance.",
      "url": "https://finnhub.io/api/news?id=82caca3ac5ad48d9f372abf1451b1472f9145e5d146a85a69ef6ec557accb14b"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Stock Up on Q2 Earnings & Revenue Beat, Margins Expand",
    "summary": "IDXX posts double-digit Q2 revenue growth, beats EPS estimates and lifts the full-year outlook as margins rise sharply.",
    "url": "https://finnhub.io/api/news?id=dd9ffa540217b317a63f215ad3948cf8d68a5a748393ed3ef2007ea07c977440",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754315700,
      "headline": "IDEXX Stock Up on Q2 Earnings & Revenue Beat, Margins Expand",
      "id": 136200387,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "IDXX posts double-digit Q2 revenue growth, beats EPS estimates and lifts the full-year outlook as margins rise sharply.",
      "url": "https://finnhub.io/api/news?id=dd9ffa540217b317a63f215ad3948cf8d68a5a748393ed3ef2007ea07c977440"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Second Quarter 2025 Earnings: Beats Expectations",
    "summary": "Boston Scientific ( NYSE:BSX ) Second Quarter 2025 Results Key Financial Results Revenue: US$5.06b (up 23% from 2Q...",
    "url": "https://finnhub.io/api/news?id=3b55a4de4cc7322e1ba0e7697b9718a3a0feb2fe07ae45b6efd6a04eb4d5eb02",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754304524,
      "headline": "Boston Scientific Second Quarter 2025 Earnings: Beats Expectations",
      "id": 136198052,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific ( NYSE:BSX ) Second Quarter 2025 Results Key Financial Results Revenue: US$5.06b (up 23% from 2Q...",
      "url": "https://finnhub.io/api/news?id=3b55a4de4cc7322e1ba0e7697b9718a3a0feb2fe07ae45b6efd6a04eb4d5eb02"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Global Life Sciences Fund Q2 2025 Commentary",
    "summary": "Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts and finding innovation upside.",
    "url": "https://finnhub.io/api/news?id=0b87039d99d7e9cf0a9a88ab06e6861b276113fa4e554693cfbacf40d7eb67b3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754288400,
      "headline": "Janus Henderson Global Life Sciences Fund Q2 2025 Commentary",
      "id": 136196996,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/172204552/image_172204552.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts and finding innovation upside.",
      "url": "https://finnhub.io/api/news?id=0b87039d99d7e9cf0a9a88ab06e6861b276113fa4e554693cfbacf40d7eb67b3"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Enterprise Fund Q2 2025 Commentary",
    "summary": "Janus Henderson shares how Enterprise Fund balanced growth and risk in Q2. See which mid-cap picks stood out and how the team is preparing for volatility.",
    "url": "https://finnhub.io/api/news?id=91562f2d11e0fbe6fbc42e92040209697aa072ebc8fd449a67e8edcae602885d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754287500,
      "headline": "Janus Henderson Enterprise Fund Q2 2025 Commentary",
      "id": 136196936,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1408826215/image_1408826215.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Janus Henderson shares how Enterprise Fund balanced growth and risk in Q2. See which mid-cap picks stood out and how the team is preparing for volatility.",
      "url": "https://finnhub.io/api/news?id=91562f2d11e0fbe6fbc42e92040209697aa072ebc8fd449a67e8edcae602885d"
    }
  }
]